REFRAME program objectives

Participating in the REFRAME Osteoporosis program will allow your practice to:

• Work with your patient records database to identify patients at risk of osteoporotic fracture in the following groups:

1. Diagnosed with osteoporosis but lapsed to their management plan
2. Aged 70 years and over who are at risk of first fracture
3. Aged over 50 years with a history of minimal trauma fracture.

• Quantify the number of at-risk patients in each group in your practice as they move from identification to appropriate management.
• Introduce an ongoing systematic review process in your practice to help you continue to identify and manage at-risk patients in the future.

Privacy Collection Statement

JHL Digital on behalf of Amgen Australia Pty Ltd (“Amgen Australia”) collects your personal information to enable us to improve the services offered by this website and to manage this website, which includes verifying your registration information and ensuring only registered healthcare professionals use the website. We also collect information about your use of our website through cookies. We will only be able to link this information to you personally if you have provided us personally identifying information whilst using the site. We may use the data we obtain through the use of cookies to customise your website experience by anticipating the information and services that may be of interest to you, to improve the functioning of our website by monitoring traffic in popular areas and to modify the services and information we provide to meet customer demand; and for our business purposes, including operation of our website, as well as research and product analyses to help us better market our products.

For this purpose, we may disclose your personal information to Amgen Australia’s related entities, as well as to trusted third parties and suppliers who assist us in providing our products and services, and market research agencies. These related entities and third parties may be located in other countries including the United States of America and in Europe and Asia. Amgen Australia remains accountable for all personal information it discloses and takes appropriate measures to ensure that the confidentiality of your information is safeguarded. For more information on privacy at Amgen Australia, including how you may access or correct your personal information or make a privacy complaint, please see our Amgen Privacy Policy or contact our Privacy Officer at: Mail: Attn: Privacy Officer, Amgen Australia Pty Ltd, Level 11, 10 Carrington St, Sydney, NSW, 2000 Email: privacyoffice@amgen.com Tel: +61 2 9870 1333

Consent Statement to receive Amgen Australia communication by email on products and services

JHL Digital and Hahn Healthcare Pty Ltd working on behalf of Amgen Australia would like to keep you updated on Amgen Australia activities, products, educational and marketing programs and invite you to events relevant to you by sending emails. For the above purposes we may disclose your personal information to Amgen Australia’s related entities, as well as to trusted third parties and suppliers who assist us in providing our products and services. These related entities and third parties may be located in other countries including the United States of America and in Europe and Asia. Amgen Australia remains accountable for all personal information it discloses and takes appropriate measures to ensure that the confidentiality of your information is safeguarded.

You may also withdraw your consent to receive such messages at any time by following the instructions provided in each electronic message sent to you.

For more information on privacy at Amgen Australia, please see our Amgen Privacy Policy or contact our Privacy Officer- Mail: Attn: Privacy Officer, Amgen Australia Pty Ltd Level 11, 10 Carrington St, Sydney, NSW, 2000 Email: privacyoffice@amgen.com Tel: +61-2-9870-1333

THIS WEBSITE IS INTENDED FOR AUSTRALIAN HEALTHCARE PROFESSIONALS ONLY

Terms of Use

PLEASE READ THESE TERMS OF USE CAREFULLY

These Terms of Use describe the terms and conditions applicable to your use of the Amgen Australia Pty Ltd’s (“Amgen”) Reframe Osteoporosis website (“website”) produced by JHL Digital.

Amgen may at any time revise or modify these Terms of Use or impose new conditions for use of this website. Such changes, revisions or modifications shall be effective immediately upon notice to you, which may be given by any means including, without limitation, posting on the website or by e-mail. Any use of the website by you after such notice shall be deemed to constitute acceptance of such changes, revisions or modifications. Amgen may modify its services at any time.

THIS WEBSITE DOES NOT PROVIDE MEDICAL OR PROFESSIONAL SERVICES ADVICE.

The content on this website is intended to be a general information resource in regard to the subject matter covered, and is provided solely on an “AS IS” and “AS AVAILABLE” basis. You are encouraged to confirm the information contained herein with other sources. Amgen is not engaged in rendering medical or similar professional services or advice via this website, and the information provided is not intended to replace independent considerations. You should not construe Amgen’s publication of this content as an endorsement by Amgen of the views expressed herein, or any warranty or guarantee of any strategy, recommendation, treatment, action, or application of medication or preparation made by the author of the content.

Amgen invites you to view, use and download a single copy of the website for your use. You are also permitted to download certain professional support and patient information which may be made available by Amgen. Except as otherwise provided on this page, no part of any content or software on the website may be copied, downloaded or stored in a retrieval system for any other purpose, nor may it be redistributed for any purpose, without the express written permission of Amgen. You understand that Amgen may discontinue, change, or restrict your use of the website for any reason without notice.

ALL CONTENT ON THE WEBSITE IS PROVIDED TO YOU ON AN “AS IS” “AS AVAILABLE” BASIS WITHOUT WARRANTY OF ANY KIND EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, AND NON-INFRINGEMENT. AMGEN MAKES NO WARRANTY AS TO THE ACCURACY, COMPLETENESS, CURRENCY, OR RELIABILITY OF ANY CONTENT AVAILABLE THROUGH THE WEBSITE. YOU ARE RESPONSIBLE FOR VERIFYING ANY INFORMATION BEFORE RELYING ON IT. USE OF THE WEBSITE AND THE CONTENT AVAILABLE ON THE WEBSITE IS AT YOUR SOLE RISK. AMGEN MAKES NO REPRESENTATIONS OR WARRANTIES THAT USE OF THE WEBSITE WILL BE UNINTERRUPTED OR ERROR-FREE. YOU ARE RESPONSIBLE FOR TAKING ALL NECESSARY PRECAUTIONS TO ENSURE THAT ANY CONTENT YOU OBTAIN FROM THE WEBSITE IS FREE OF VIRUSES.

The above exclusions may not apply in jurisdictions that do not allow the exclusion of certain implied warranties.

YOUR USE OF THE WEBSITE OR ANY CONTENT ON THE WEBSITE IS AT YOUR OWN RISK. AMGEN SPECIFICALLY DISCLAIMS ANY LIABILITY, WHETHER BASED IN CONTRACT, TORT, STRICT LIABILITY OR OTHERWISE, FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, OR SPECIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH ACCESS TO OR USE OF THE WEB SITE, EVEN IF AMGEN HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, INCLUDING BUT NOT LIMITED TO RELIANCE BY ANY PARTY ON ANY CONTENT OBTAINED THROUGH THE USE OF THE WEBSITE, OR THAT ARISES IN CONNECTION WITH MISTAKES OR OMISSIONS IN, OR DELAYS IN TRANSMISSION OF, INFORMATION TO OR FROM THE USER, INTERRUPTIONS IN TELECOMMUNICATIONS CONNECTIONS TO THE WEBSITE OR VIRUSES, WHETHER CAUSED IN WHOLE OR IN PART BY NEGLIGENCE, ACTS OF GOD, WAR, TERRORISM, TELECOMMUNICATIONS FAILURE, THEFT OR DESTRUCTION OF, OR UNAUTHORIZED ACCESS TO THE WEBSITE, OR RELATED INFORMATION OR PROGRAMS.

If you violate any of these Terms of Use or if you misuse the website, you agree to defend, indemnify and hold harmless Amgen, its officers, directors, employees, agents and licensees from any and all liability including costs, expenses and attorneys’ fees that arise out of or are related to your violation or misuse.

Certain areas of this website enable you to submit e-mails, or otherwise provide feedback or information to Amgen.

You agree that by submitting content:

that you will not submit any information that would directly identify any individual or any information for which you do not have all necessary consents or authorisations to disclose;

you will only submit content that complies with applicable law, and will not submit content that is abusive, defamatory, obscene, infringing, threatening, repetitive, or otherwise inappropriate, or that contains any viruses or other software that may adversely affect the operation of another’s computer;

you understand and agree that such content that is submitted to a feedback page, will be deemed non-confidential; and

you grant to Amgen the irrevocable right to use, copy, modify, publish, perform, transmit and display such content via any media in accordance with these Terms of Use, and waive any moral rights you may have in such content. Subject to all applicable federal laws, Amgen shall be free to use such content, including any ideas, concepts, know-how, or techniques contained in such content, for any reason whatsoever.

All Amgen trademarks are the exclusive property of Amgen or companies within the Amgen group. Unauthorised use of any trademark, service mark or logo may be a violation of trademark laws.

This website is protected by Australian and foreign copyright laws. Except for your informational, personal, non-commercial use as authorised above, you may not modify, reproduce or distribute the design or layout of the website or individual sections of the design or layout of the website or Amgen logos without Amgen’s written permission.

The website contains information, news and/or press releases in relation to cardiovascular disease, familial hypercholesterolemia and other cardiology conditions, as well as certain Amgen products. While this information was believed to be accurate as of the date it was prepared, Amgen disclaims any duty or obligation to update this information, news or any press releases. Information about companies other than Amgen contained in the news, press releases or otherwise, should not be relied upon as being provided or endorsed by Amgen.

The website may contain links to websites operated by other parties. The linked sites are not under the control of Amgen, and Amgen is not responsible for the content available on any other Internet sites linked to the website. Such links do not imply Amgen’s endorsement of material on any other site and Amgen disclaims all liability with regard to your access to such linked websites. Amgen provides links to other Internet sites as a convenience to users, and access to any other Internet sites linked to this website is at your own risk.

This website requires you to register prior to permitting access to the website or certain services available on this site. You are responsible for maintaining the confidentiality of your registration information and password, and for all uses of your password, whether or not authorised by you.

This website is operated by Amgen from its offices in New South Wales, Australia. The law of the State of New South Wales and Australia shall govern these terms and conditions, without reference to its choice of law rules. Amgen makes no representation that the information in the website is appropriate or available for use in other locations, and access to this website from territories where the content of this website may be illegal is prohibited. Those who choose to access this website from other locations do so on their own initiative and are responsible for compliance with applicable local laws.

Any controversy or claim arising under or related to these Terms of Use or Amgen’s products and/or services shall be submitted to courts of competent jurisdiction in New South Wales and courts entitled to hear appeals therefrom.

Amgen reserves the right to seek all remedies available at law and in equity for violations of these Terms of Use, including the right to block access from a particular Internet address to the website.

All personal information will be collected, used and disclosed by JHL Digital for the purposes of administering Reframe Osteoporosis™ (in accordance with the privacy collection statement appearing on this website).

If you have any questions about these Terms of Use, please contact us.

THIS WEBSITE IS INTENDED FOR AUSTRALIAN HEALTHCARE PROFESSIONALS ONLY